Logo image of SMCRT.OL

SMARTCRAFT ASA (SMCRT.OL) Stock Fundamental Analysis

Europe - OSL:SMCRT - NO0011008971 - Common Stock

26 NOK
0 (0%)
Last: 9/15/2025, 4:19:41 PM
Fundamental Rating

6

Overall SMCRT gets a fundamental rating of 6 out of 10. We evaluated SMCRT against 103 industry peers in the Software industry. SMCRT scores excellent on profitability, but there are some minor concerns on its financial health. SMCRT shows excellent growth, but is valued quite expensive already. With these ratings, SMCRT could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

SMCRT had positive earnings in the past year.
In the past year SMCRT had a positive cash flow from operations.
Each year in the past 5 years SMCRT has been profitable.
SMCRT had a positive operating cash flow in each of the past 5 years.
SMCRT.OL Yearly Net Income VS EBIT VS OCF VS FCFSMCRT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

With a decent Return On Assets value of 7.53%, SMCRT is doing good in the industry, outperforming 72.82% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.48%, SMCRT is in line with its industry, outperforming 59.22% of the companies in the same industry.
SMCRT has a Return On Invested Capital of 9.69%. This is in the better half of the industry: SMCRT outperforms 75.73% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SMCRT is in line with the industry average of 12.80%.
Industry RankSector Rank
ROA 7.53%
ROE 10.48%
ROIC 9.69%
ROA(3y)8.35%
ROA(5y)6.97%
ROE(3y)11.09%
ROE(5y)10.12%
ROIC(3y)11.14%
ROIC(5y)10.01%
SMCRT.OL Yearly ROA, ROE, ROICSMCRT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

SMCRT has a Profit Margin of 18.01%. This is in the better half of the industry: SMCRT outperforms 74.76% of its industry peers.
In the last couple of years the Profit Margin of SMCRT has grown nicely.
SMCRT has a Operating Margin of 23.10%. This is amongst the best in the industry. SMCRT outperforms 81.55% of its industry peers.
In the last couple of years the Operating Margin of SMCRT has remained more or less at the same level.
SMCRT has a better Gross Margin (91.34%) than 91.26% of its industry peers.
SMCRT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.1%
PM (TTM) 18.01%
GM 91.34%
OM growth 3Y4.37%
OM growth 5Y0.76%
PM growth 3Y15.25%
PM growth 5Y2.97%
GM growth 3Y3.1%
GM growth 5Y0.76%
SMCRT.OL Yearly Profit, Operating, Gross MarginsSMCRT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SMCRT is creating some value.
The number of shares outstanding for SMCRT has been reduced compared to 1 year ago.
SMCRT has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for SMCRT is higher compared to a year ago.
SMCRT.OL Yearly Shares OutstandingSMCRT.OL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SMCRT.OL Yearly Total Debt VS Total AssetsSMCRT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 8.38 indicates that SMCRT is not in any danger for bankruptcy at the moment.
SMCRT has a better Altman-Z score (8.38) than 84.47% of its industry peers.
The Debt to FCF ratio of SMCRT is 0.34, which is an excellent value as it means it would take SMCRT, only 0.34 years of fcf income to pay off all of its debts.
SMCRT has a Debt to FCF ratio of 0.34. This is amongst the best in the industry. SMCRT outperforms 91.26% of its industry peers.
SMCRT has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
SMCRT's Debt to Equity ratio of 0.02 is amongst the best of the industry. SMCRT outperforms 89.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.34
Altman-Z 8.38
ROIC/WACC1.12
WACC8.67%
SMCRT.OL Yearly LT Debt VS Equity VS FCFSMCRT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

SMCRT has a Current Ratio of 0.82. This is a bad value and indicates that SMCRT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.82, SMCRT is not doing good in the industry: 74.76% of the companies in the same industry are doing better.
A Quick Ratio of 0.82 indicates that SMCRT may have some problems paying its short term obligations.
SMCRT's Quick ratio of 0.82 is on the low side compared to the rest of the industry. SMCRT is outperformed by 74.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
SMCRT.OL Yearly Current Assets VS Current LiabilitesSMCRT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The earnings per share for SMCRT have decreased strongly by -13.51% in the last year.
Measured over the past years, SMCRT shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.82% on average per year.
The Revenue has grown by 27.16% in the past year. This is a very strong growth!
Measured over the past years, SMCRT shows a very strong growth in Revenue. The Revenue has been growing by 27.15% on average per year.
EPS 1Y (TTM)-13.51%
EPS 3Y38.9%
EPS 5Y30.82%
EPS Q2Q%-3.41%
Revenue 1Y (TTM)27.16%
Revenue growth 3Y23.56%
Revenue growth 5Y27.15%
Sales Q2Q%5.68%

3.2 Future

SMCRT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.71% yearly.
Based on estimates for the next years, SMCRT will show a quite strong growth in Revenue. The Revenue will grow by 13.72% on average per year.
EPS Next Y-7.49%
EPS Next 2Y14.75%
EPS Next 3Y20.54%
EPS Next 5Y20.71%
Revenue Next Year10.53%
Revenue Next 2Y11.12%
Revenue Next 3Y12.41%
Revenue Next 5Y13.72%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SMCRT.OL Yearly Revenue VS EstimatesSMCRT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
SMCRT.OL Yearly EPS VS EstimatesSMCRT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2 2.5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 43.33 indicates a quite expensive valuation of SMCRT.
Compared to the rest of the industry, the Price/Earnings ratio of SMCRT is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.30, SMCRT is valued quite expensively.
Based on the Price/Forward Earnings ratio of 29.56, the valuation of SMCRT can be described as expensive.
Based on the Price/Forward Earnings ratio, SMCRT is valued a bit cheaper than the industry average as 60.19% of the companies are valued more expensively.
SMCRT's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.73.
Industry RankSector Rank
PE 43.33
Fwd PE 29.56
SMCRT.OL Price Earnings VS Forward Price EarningsSMCRT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SMCRT.
The rest of the industry has a similar Price/Free Cash Flow ratio as SMCRT.
Industry RankSector Rank
P/FCF 42.03
EV/EBITDA 20.65
SMCRT.OL Per share dataSMCRT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

The decent profitability rating of SMCRT may justify a higher PE ratio.
SMCRT's earnings are expected to grow with 20.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)1.41
EPS Next 2Y14.75%
EPS Next 3Y20.54%

0

5. Dividend

5.1 Amount

No dividends for SMCRT!.
Industry RankSector Rank
Dividend Yield N/A

SMARTCRAFT ASA

OSL:SMCRT (9/15/2025, 4:19:41 PM)

26

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-26 2025-08-26/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners40.99%
Inst Owner ChangeN/A
Ins Owners1%
Ins Owner ChangeN/A
Market Cap4.46B
Analysts83.08
Price Target31.62 (21.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.93%
Min EPS beat(2)-22.72%
Max EPS beat(2)-19.14%
EPS beat(4)0
Avg EPS beat(4)-18.48%
Min EPS beat(4)-22.72%
Max EPS beat(4)-10.07%
EPS beat(8)1
Avg EPS beat(8)-5.84%
EPS beat(12)3
Avg EPS beat(12)-4.62%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.84%
Min Revenue beat(2)-6.15%
Max Revenue beat(2)-5.52%
Revenue beat(4)0
Avg Revenue beat(4)-4.65%
Min Revenue beat(4)-6.79%
Max Revenue beat(4)-0.13%
Revenue beat(8)0
Avg Revenue beat(8)-3.67%
Revenue beat(12)1
Avg Revenue beat(12)-3.83%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.46%
PT rev (3m)-2.46%
EPS NQ rev (1m)-1%
EPS NQ rev (3m)3.13%
EPS NY rev (1m)-20.35%
EPS NY rev (3m)-20.35%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-1.24%
Revenue NY rev (1m)-1.74%
Revenue NY rev (3m)-1.91%
Valuation
Industry RankSector Rank
PE 43.33
Fwd PE 29.56
P/S 8.29
P/FCF 42.03
P/OCF 27.91
P/B 4.82
P/tB N/A
EV/EBITDA 20.65
EPS(TTM)0.6
EY2.31%
EPS(NY)0.88
Fwd EY3.38%
FCF(TTM)0.62
FCFY2.38%
OCF(TTM)0.93
OCFY3.58%
SpS3.14
BVpS5.39
TBVpS-0.59
PEG (NY)N/A
PEG (5Y)1.41
Profitability
Industry RankSector Rank
ROA 7.53%
ROE 10.48%
ROCE 12.24%
ROIC 9.69%
ROICexc 11.4%
ROICexgc N/A
OM 23.1%
PM (TTM) 18.01%
GM 91.34%
FCFM 19.72%
ROA(3y)8.35%
ROA(5y)6.97%
ROE(3y)11.09%
ROE(5y)10.12%
ROIC(3y)11.14%
ROIC(5y)10.01%
ROICexc(3y)13.91%
ROICexc(5y)12.37%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.07%
ROCE(5y)12.65%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y12.62%
ROICexc growth 5Y9.01%
OM growth 3Y4.37%
OM growth 5Y0.76%
PM growth 3Y15.25%
PM growth 5Y2.97%
GM growth 3Y3.1%
GM growth 5Y0.76%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.34
Debt/EBITDA 0.1
Cap/Depr 62.43%
Cap/Sales 9.98%
Interest Coverage 39.01
Cash Conversion 75.98%
Profit Quality 109.5%
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z 8.38
F-Score6
WACC8.67%
ROIC/WACC1.12
Cap/Depr(3y)89.02%
Cap/Depr(5y)87.97%
Cap/Sales(3y)9.14%
Cap/Sales(5y)8.43%
Profit Quality(3y)114.47%
Profit Quality(5y)158.42%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.51%
EPS 3Y38.9%
EPS 5Y30.82%
EPS Q2Q%-3.41%
EPS Next Y-7.49%
EPS Next 2Y14.75%
EPS Next 3Y20.54%
EPS Next 5Y20.71%
Revenue 1Y (TTM)27.16%
Revenue growth 3Y23.56%
Revenue growth 5Y27.15%
Sales Q2Q%5.68%
Revenue Next Year10.53%
Revenue Next 2Y11.12%
Revenue Next 3Y12.41%
Revenue Next 5Y13.72%
EBIT growth 1Y-6.86%
EBIT growth 3Y28.96%
EBIT growth 5Y28.12%
EBIT Next Year50.64%
EBIT Next 3Y29.8%
EBIT Next 5Y24.92%
FCF growth 1Y5.25%
FCF growth 3Y14.53%
FCF growth 5Y29.46%
OCF growth 1Y22.78%
OCF growth 3Y18.89%
OCF growth 5Y30.95%